Clearance of Lynkuet provides a new alternative to hormone-based treatment for hot flashes and sets up a market battle with ...
Lynkuet is the first FDA-approved therapy that blocks both the neurokinin 1 and neurokinin 3 receptors to treat hot flashes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback